{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T11:42:22Z","timestamp":1791286942953,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1007\/s10096-013-2023-5","type":"journal-article","created":{"date-parts":[[2013,11,30]],"date-time":"2013-11-30T07:45:37Z","timestamp":1385797537000},"page":"845-851","source":"Crossref","is-referenced-by-count":40,"title":["Combination therapy with iron chelation and vancomycin in treating murine staphylococcemia"],"prefix":"10.1007","volume":"33","author":[{"given":"G.","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Spellberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Gebremariam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y. Q.","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. W.","family":"French","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Bayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. S.","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,12,1]]},"reference":[{"issue":"1","key":"2023_CR1","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.meegid.2008.09.012","volume":"9","author":"A Belkum van","year":"2009","unstructured":"van Belkum A, Melles DC, Nouwen J, van Leeuwen WB, van Wamel W, Vos MC, Wertheim HF, Verbrugh HA (2009) Co-evolutionary aspects of human colonisation and infection by Staphylococcus aureus. Infect Genet Evol 9(1):32\u201347","journal-title":"Infect Genet Evol"},{"issue":"10","key":"2023_CR2","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1001\/archderm.143.10.1259","volume":"143","author":"PM Mertz","year":"2007","unstructured":"Mertz PM, Cardenas TC, Snyder RV, Kinney MA, Davis SC, Plano LR (2007) Staphylococcus aureus virulence factors associated with infected skin lesions: influence on the local immune response. Arch Dermatol 143(10):1259\u20131263","journal-title":"Arch Dermatol"},{"issue":"1","key":"2023_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/dkm410","volume":"61","author":"BC Millar","year":"2008","unstructured":"Millar BC, Prendergast BD, Moore JE (2008) Community-associated MRSA (CA-MRSA): an emerging pathogen in infective endocarditis. J Antimicrob Chemother 61(1):1\u20137","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"2023_CR4","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/BPO.0b013e31817bb816","volume":"28","author":"J Saavedra-Lozano","year":"2008","unstructured":"Saavedra-Lozano J, Mej\u00edas A, Ahmad N, Peromingo E, Ardura MI, Guillen S, Syed A, Cavuoti D, Ramilo O (2008) Changing trends in acute osteomyelitis in children: impact of methicillin-resistant Staphylococcus aureus infections. J Pediatr Orthop 28(5):569\u2013575","journal-title":"J Pediatr Orthop"},{"issue":"11","key":"2023_CR5","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1001\/archinte.1995.00430110089009","volume":"155","author":"D Pittet","year":"1995","unstructured":"Pittet D, Wenzel RP (1995) Nosocomial bloodstream infections. Secular trends in rates, mortality, and contribution to total hospital deaths. Arch Intern Med 155(11):1177\u20131184","journal-title":"Arch Intern Med"},{"key":"2023_CR6","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1146\/annurev-micro-090110-102851","volume":"65","author":"ND Hammer","year":"2011","unstructured":"Hammer ND, Skaar EP (2011) Molecular mechanisms of Staphylococcus aureus iron acquisition. Annu Rev Microbiol 65:129\u2013147","journal-title":"Annu Rev Microbiol"},{"issue":"5608","key":"2023_CR7","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1126\/science.1081147","volume":"299","author":"SK Mazmanian","year":"2003","unstructured":"Mazmanian SK, Skaar EP, Gaspar AH, Humayun M, Gornicki P, Jelenska J, Joachmiak A, Missiakas DM, Schneewind O (2003) Passage of heme-iron across the envelope of Staphylococcus aureus. Science 299(5608):906\u2013909","journal-title":"Science"},{"issue":"3","key":"2023_CR8","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.bbrc.2004.06.025","volume":"320","author":"J Mack","year":"2004","unstructured":"Mack J, Vermeiren C, Heinrichs DE, Stillman MJ (2004) In vivo heme scavenging by Staphylococcus aureus IsdC and IsdE proteins. Biochem Biophys Res Commun 320(3):781\u2013788","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"2023_CR9","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.micinf.2003.12.008","volume":"6","author":"EP Skaar","year":"2004","unstructured":"Skaar EP, Schneewind O (2004) Iron-regulated surface determinants (Isd) of Staphylococcus aureus: stealing iron from heme. Microbes Infect 6(4):390\u2013397","journal-title":"Microbes Infect"},{"issue":"40","key":"2023_CR10","doi-asserted-by":"crossref","first-page":"16578","DOI":"10.1021\/ja305115y","volume":"134","author":"MT Tiedemann","year":"2012","unstructured":"Tiedemann MT, Heinrichs DE, Stillman MJ (2012) Multiprotein heme shuttle pathway in Staphylococcus aureus: iron-regulated surface determinant cog-wheel kinetics. J Am Chem Soc 134(40):16578\u201316585","journal-title":"J Am Chem Soc"},{"issue":"1","key":"2023_CR11","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1432-1033.1990.tb19094.x","volume":"191","author":"S Konetschny-Rapp","year":"1990","unstructured":"Konetschny-Rapp S, Jung G, Meiwes J, Z\u00e4hner H (1990) Staphyloferrin A: a structurally new siderophore from staphylococci. Eur J Biochem 191(1):65\u201374","journal-title":"Eur J Biochem"},{"issue":"3","key":"2023_CR12","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/BF00205858","volume":"6","author":"H Drechsel","year":"1993","unstructured":"Drechsel H, Freund S, Nicholson G, Haag H, Jung O, Z\u00e4hner H, Jung G (1993) Purification and chemical characterization of staphyloferrin B, a hydrophilic siderophore from staphylococci. Biometals 6(3):185\u2013192","journal-title":"Biometals"},{"issue":"5","key":"2023_CR13","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1128\/IAI.65.5.1944-1948.1997","volume":"65","author":"RJ Courcol","year":"1997","unstructured":"Courcol RJ, Trivier D, Bissinger MC, Martin GR, Brown MR (1997) Siderophore production by Staphylococcus aureus and identification of iron-regulated proteins. Infect Immun 65(5):1944\u20131948","journal-title":"Infect Immun"},{"issue":"3","key":"2023_CR14","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1128\/IAI.67.3.1086-1092.1999","volume":"67","author":"B Modun","year":"1999","unstructured":"Modun B, Williams P (1999) The staphylococcal transferrin-binding protein is a cell wall glyceraldehyde-3-phosphate dehydrogenase. Infect Immun 67(3):1086\u20131092","journal-title":"Infect Immun"},{"issue":"9","key":"2023_CR15","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1002\/lt.21587","volume":"14","author":"N Singh","year":"2008","unstructured":"Singh N, Sun HY (2008) Iron overload and unique susceptibility of liver transplant recipients to disseminated disease due to opportunistic pathogens. Liver Transpl 14(9):1249\u20131255","journal-title":"Liver Transpl"},{"issue":"9","key":"2023_CR16","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1172\/JCI32338","volume":"117","author":"AS Ibrahim","year":"2007","unstructured":"Ibrahim AS, Gebermariam T, Fu Y, Lin L, Husseiny MI, French SW, Schwartz J, Skory CD, Edwards JE Jr, Spellberg BJ (2007) The iron chelator deferasirox protects mice from mucormycosis through iron starvation. J Clin Invest 117(9):2649\u20132657","journal-title":"J Clin Invest"},{"issue":"2","key":"2023_CR17","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1093\/jac\/dkp426","volume":"65","author":"AS Ibrahim","year":"2010","unstructured":"Ibrahim AS, Gebremariam T, French SW, Edwards JE Jr, Spellberg B (2010) The iron chelator deferasirox enhances liposomal amphotericin B efficacy in treating murine invasive pulmonary aspergillosis. J Antimicrob Chemother 65(2):289\u2013292","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"2023_CR18","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1128\/AAC.01577-10","volume":"55","author":"AS Ibrahim","year":"2011","unstructured":"Ibrahim AS, Gebremariam T, Luo G, Fu Y, French SW, Edwards JE Jr, Spellberg B (2011) Combination therapy of murine mucormycosis or aspergillosis with iron chelation, polyenes, and echinocandins. Antimicrob Agents Chemother 55(4):1768\u20131770","journal-title":"Antimicrob Agents Chemother"},{"key":"2023_CR19","unstructured":"Clinical and Laboratory Standards Institute (CLSI) (2009) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. CLSI, Wayne, PA"},{"issue":"8","key":"2023_CR20","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1111\/j.1469-0691.2008.02035.x","volume":"14","author":"S Lemaire","year":"2008","unstructured":"Lemaire S, Kosowska-Shick K, Julian K, Tulkens PM, Van Bambeke F, Appelbaum PC (2008) Activities of antistaphylococcal antibiotics towards the extracellular and intraphagocytic forms of Staphylococcus aureus isolates from a patient with persistent bacteraemia and endocarditis. Clin Microbiol Infect 14(8):766\u2013777","journal-title":"Clin Microbiol Infect"},{"issue":"5","key":"2023_CR21","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1086\/342046","volume":"186","author":"YQ Xiong","year":"2002","unstructured":"Xiong YQ, Van Wamel W, Nast CC, Yeaman MR, Cheung AL, Bayer AS (2002) Activation and transcriptional interaction between agr RNAII and RNAIII in Staphylococcus aureus in vitro and in an experimental endocarditis model. J Infect Dis 186(5):668\u2013677","journal-title":"J Infect Dis"},{"issue":"9","key":"2023_CR22","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1086\/508210","volume":"194","author":"YQ Xiong","year":"2006","unstructured":"Xiong YQ, Willard J, Yeaman MR, Cheung AL, Bayer AS (2006) Regulation of Staphylococcus aureus alpha-toxin gene (hla) expression by agr, sarA, and sae in vitro and in experimental infective endocarditis. J Infect Dis 194(9):1267\u20131275","journal-title":"J Infect Dis"},{"issue":"5","key":"2023_CR23","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1128\/AAC.00833-08","volume":"53","author":"JJ Hilliard","year":"2009","unstructured":"Hilliard JJ, Fernandez J, Melton J, Macielag MJ, Goldschmidt R, Bush K, Abbanat D (2009) In vivo activity of the pyrrolopyrazolyl-substituted oxazolidinone RWJ-416457. Antimicrob Agents Chemother 53(5):2028\u20132033","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"2023_CR24","first-page":"97","volume":"13","author":"E Pistella","year":"2005","unstructured":"Pistella E, Falcone M, Baiocchi P, Pompeo ME, Pierciaccante A, Penni A, Venditti M (2005) In vitro activity of fosfomycin in combination with vancomycin or teicoplanin against Staphylococcus aureus isolated from device-associated infections unresponsive to glycopeptide therapy. Infez Med 13(2):97\u2013102","journal-title":"Infez Med"},{"issue":"10","key":"2023_CR25","doi-asserted-by":"crossref","first-page":"4016","DOI":"10.1128\/AAC.48.10.4016-4019.2004","volume":"48","author":"SA Shelburne","year":"2004","unstructured":"Shelburne SA, Musher DM, Hulten K, Ceasar H, Lu MY, Bhaila I, Hamill RJ (2004) In vitro killing of community-associated methicillin-resistant Staphylococcus aureus with drug combinations. Antimicrob Agents Chemother 48(10):4016\u20134019","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"2023_CR26","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1128\/AAC.46.8.2606-2612.2002","volume":"46","author":"GP Allen","year":"2002","unstructured":"Allen GP, Cha R, Rybak MJ (2002) In vitro activities of quinupristin\u2013dalfopristin and cefepime, alone and in combination with various antimicrobials, against multidrug-resistant staphylococci and enterococci in an in vitro pharmacodynamic model. Antimicrob Agents Chemother 46(8):2606\u20132612","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"2023_CR27","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1128\/AAC.27.3.357","volume":"27","author":"GM Eliopoulos","year":"1985","unstructured":"Eliopoulos GM, Thauvin C, Gerson B, Moellering RC Jr (1985) In vitro activity and mechanism of action of A21978C1, a novel cyclic lipopeptide antibiotic. Antimicrob Agents Chemother 27(3):357\u2013362","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"2023_CR28","doi-asserted-by":"crossref","first-page":"E139","DOI":"10.1532\/HSF98.20101098","volume":"14","author":"S Attaran","year":"2011","unstructured":"Attaran S, Wragg A, Awad WI (2011) Aortic valve endocarditis with splenic and brain abscesses: difficult management issues. Heart Surg Forum 14(2):E139\u2013E141","journal-title":"Heart Surg Forum"},{"issue":"4","key":"2023_CR29","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1136\/adc.2007.135939","volume":"94","author":"PN Goldwater","year":"2009","unstructured":"Goldwater PN (2009) Sterile site infection at autopsy in sudden unexpected deaths in infancy. Arch Dis Child 94(4):303\u2013307","journal-title":"Arch Dis Child"},{"issue":"12","key":"2023_CR30","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1002\/lt.20827","volume":"12","author":"J Alexander","year":"2006","unstructured":"Alexander J, Limaye AP, Ko CW, Bronner MP, Kowdley KV (2006) Association of hepatic iron overload with invasive fungal infection in liver transplant recipients. Liver Transpl 12(12):1799\u20131804","journal-title":"Liver Transpl"},{"issue":"5","key":"2023_CR31","first-page":"605","volume":"20","author":"G Weiss","year":"1992","unstructured":"Weiss G, Fuchs D, Hausen A, Reibnegger G, Werner ER, Werner-Felmayer G, Wachter H (1992) Iron modulates interferon-gamma effects in the human myelomonocytic cell line THP-1. Exp Hematol 20(5):605\u2013610","journal-title":"Exp Hematol"},{"issue":"1","key":"2023_CR32","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1074\/jbc.M307952200","volume":"279","author":"EP Skaar","year":"2004","unstructured":"Skaar EP, Gaspar AH, Schneewind O (2004) IsdG and IsdI, heme-degrading enzymes in the cytoplasm of Staphylococcus aureus. J Biol Chem 279(1):436\u2013443","journal-title":"J Biol Chem"},{"key":"2023_CR33","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/978-1-4615-0593-8_10","volume":"509","author":"H Nick","year":"2002","unstructured":"Nick H, Wong A, Acklin P, Faller B, Jin Y, Lattmann R, Sergejew T, Hauffe S, Thomas H, Schnebli HP (2002) ICL670A: preclinical profile. Adv Exp Med Biol 509:185\u2013203","journal-title":"Adv Exp Med Biol"},{"issue":"9369","key":"2023_CR34","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/S0140-6736(03)13309-0","volume":"361","author":"E Nisbet-Brown","year":"2003","unstructured":"Nisbet-Brown E, Olivieri NF, Giardina PJ, Grady RW, Neufeld EJ, S\u00e9chaud R, Krebs-Brown AJ, Anderson JR, Alberti D, Sizer KC, Nathan DG (2003) Effectiveness and safety of ICL670 in iron-loaded patients with thalassaemia: a randomised, double-blind, placebo-controlled, dose-escalation trial. Lancet 361(9369):1597\u20131602","journal-title":"Lancet"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-013-2023-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10096-013-2023-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-013-2023-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,11]],"date-time":"2020-08-11T02:46:56Z","timestamp":1597114016000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10096-013-2023-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12,1]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["2023"],"URL":"https:\/\/doi.org\/10.1007\/s10096-013-2023-5","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12,1]]}}}